Antiapoptotic activity by HIV protease inhibitors either alone or boostered

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):545-6. doi: 10.1097/00126334-200212150-00015.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Apoptosis / drug effects*
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / pathology
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / pathology
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / pharmacology*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Male

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors